Loading...
Cerus Corporation reported a 41% increase in total revenue, reaching $37.8 million in Q2 2021, driven by a 46% increase in product revenue to $31.5 million. The company raised its full-year product revenue guidance to $118-122 million.
Total revenue increased by 41% to $37.8 million in the second quarter of 2021.
Product revenue grew by 46% to $31.5 million, led by a 128% increase in North America.
The company is increasing its 2021 annual product revenue guidance to $118 million to $122 million.
Submitted PMA supplement to U.S. FDA for 7-day storage of INTERCEPT platelets.
The Company now expects 2021 product revenue to be in the range of $118 million to $122 million.